This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2023
  • /
  • 9
  • /
  • Journal of Cosmetic Dermatology publishes data dem...
News

Journal of Cosmetic Dermatology publishes data demonstrating patient satisfaction with natural-looking outcomes following treatment with BOTOX Cosmetic.- Allergan Aesthetics.

Read time: 1 mins
Published:2nd Sep 2023

Allergan Aesthetics, an AbbVie company announced the Journal of Cosmetic Dermatology published results from a year-long, post-hoc analysis of patient-reported outcomes (PROs) from two Phase III clinical studies evaluating the impact of onabotulinumtoxinA (BOTOX Cosmetic) on upper facial lines (UFLs) in adults new to toxin treatment.

 

The peer-reviewed study found that, 30 days after receiving treatment, 90.5% of all study patients reported being either mostly or very satisfied with receiving a natural look, as rated on a five-point scale. This satisfaction was sustained by more than 80% of patients throughout the 12-month study period for the temporary improvement in the appearance of their moderate to severe UFLs. In addition, 30 days after receiving treatment, more than half of treated patients reported an improvement in self-perceived appearance and psychological well-being, defined as those who achieved a meaningful improvement in five areas (how much their facial lines made them feel older, feel unhappy, look angry, look tired, or feel that they negatively affected self-esteem).

UFLs, which include forehead, glabellar, and crow's feet lines, fall within the main areas of concern for individuals considering aesthetic treatments. The study, titled "Self-Perception of Natural Outcome, Appearance and Emotional Well-Being After OnabotulinumtoxinA Treatment for Upper Facial Lines: Post-Hoc Analysis Across Age and Gender" , analyzed patient-reported outcomes (PROs) from more than 450 neurotoxin-naïve adults treated who saw a reduction in UFL severity with onabotulinumtoxinA (BOTOX Cosmetic) .

The study used the Facial Line Satisfaction Questionnaire, a validated proprietary questionnaire developed according to FDA guidelines for PRO measures, which assesses treatment satisfaction, appearance, and emotional impact as perceived by patients.

"Regardless of age or gender, most patients contemplating facial aesthetic treatments desire refreshed, natural-looking results, and fear of looking unnatural or a 'frozen' look is a common barrier for many," said Steven Dayan, MD, founder of Denova Research and study author. "Self-perceived patient satisfaction, both in physical appearance and emotional wellbeing, is paramount in aesthetics medicine and it is vital physicians understand how patients perceive themselves after treatment to truly address patient concerns and help fulfill their expectations."

See-Dayan, S., Ogilvie, P., et al." Self-Perception of Natural Outcome, Appearance and Emotional Well-Being After OnabotulinumtoxinA Treatment for Upper Facial Lines: Post-Hoc Analysis Across Age and Gender". J Cosmet Dermatol. Published online August 24, 2023. doi: 10.1111/jocd.15947.

Condition: Upper Facial Lines
Type: drug

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Related news and insights